Litigation for naltrexone

US Court Litigation for naltrexone

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
6,264,987		15-1659|Fed. Cir.	2015-05-13			Court of Appeals for the Federal Circuit
6,264,987		2:20-cv-12470|D.N.J.	2020-09-09	2023-08-30	28:1338 Patent Infringement	District Court, D. New Jersey	None
6,264,987		2:20-cv-12470|D.N.J.	2020-09-09	2023-08-30	28:1338 Patent Infringement	District Court, D. New Jersey	None
6,667,061	Alkermes Pharma Ireland Limited v. Luye Pharma Group Ltd.	1:19-cv-01340|D. Del.	2019-07-17	2019-12-02	35:271 Patent Infringement	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for naltrexone

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
6,667,061	Luye Pharma Group Ltd. et al.		2016-05-31	05-31-2016	Alkermes Controlled Therapeutics, Inc.	Inter partes review		11-30-2016	J. Ramstack
6,667,061	Luye Pharma Group Ltd. et al.		2016-05-31	05-31-2016	Alkermes Controlled Therapeutics, Inc.	Inter partes review		11-30-2016	J. Ramstack
7,919,499	Amneal Pharmaceuticals LLC		2018-04-20	05-09-2018	Ehrich, Elliot	Inter partes review		11-07-2018
7,919,499	Apotex Inc. et al.		2025-01-30	01-30-2025		Inter partes review		07-02-2025	Ehrich, Elliot